We are live on ! Find out more
CG

Carlyle Group Portfolio holdings

AUM $10.6B
1-Year Est. Return 11.25%
This Fund
S&P 500
This Quarter Est. Return
+3.42%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$2.81B
AUM Growth
-$545M
Cap. Flow
-$547M
Cap. Flow %
-19.48%
Top 10 Hldgs %
96.38%
Holding
30
New
–
Increased
3
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
PHAT icon
Phathom Pharmaceuticals
PHAT
+$6.48M
2
OKUR
OnKure Therapeutics
OKUR
+$5.04M
3
SMHI icon
SEACOR Marine Holdings
SMHI
+$1.07K

Top Sells

Rank Stock Value
1
MKSI icon
MKS Inc
MKSI
+$458M
2
PCVX icon
Vaxcyte
PCVX
+$72.1M
3
LSI
Life Storage, Inc.
LSI
+$11.3M
4
GETY icon
Getty Images
GETY
+$11M
5
VERA icon
Vera Therapeutics
VERA
+$4.91M

Sector Composition

Rank Sector Weight
1 Technology 48.16%
2 Healthcare 44.89%
3 Consumer Staples 3.58%
4 Communication Services 1.73%
5 Real Estate 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTEM
26
DELISTED
Molecular Templates, Inc.
MTEM
$92K ﹤0.01%
13,333
– –
PCVX icon
27
Vaxcyte
PCVX
$8.12B
– –
-1,923,158
Closed -$72.1M
CBAY
28
DELISTED
Cymabay Therapeutics
CBAY
– –
-131,036
Closed -$1.14M
SIEN
29
DELISTED
Sientra, Inc.
SIEN
– –
-167,358
Closed -$256K
LSI
30
DELISTED
Life Storage, Inc.
LSI
– –
-86,000
Closed -$11.3M
1
2

Similar funds

SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
BMSSC
B. Metzler seel. Sohn & Co Frankfurt, Germany $10.8B AUM 21.99% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

Carlyle Group's Q2 2023 Portfolio in Review

As of Q2 2023, Carlyle Group held 30 positions worth $2.81B, down 16% from $3.35B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Carlyle Group withdrew a net $547M in Q2 2023, closing 4 positions and reducing 3 holdings. Its most notable exit was Vaxcyte, an estimated $72.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 48% of assets, down from 52% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Carlyle Group added an estimated $6.48M to Phathom Pharmaceuticals.

  • Carlyle Group added most to Phathom Pharmaceuticals in Q2 2023, an estimated $6.48M increase.
  • Carlyle Group's biggest Q2 2023 reduction was MKS Inc, cutting an estimated $458M.
  • Carlyle Group fully exited Vaxcyte in Q2 2023, selling an estimated $72.1M.
  • Carlyle Group's ten largest holdings make up 96% of its $2.81B portfolio in Q2 2023.
  • Carlyle Group opened 0 new positions and closed 4 in Q2 2023.
  • Carlyle Group's portfolio value fell 16% quarter-over-quarter to $2.81B.

Based on Carlyle Group's 13F filing for Q2 2023, filed 4 Aug 2023.